PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trialConnie Celum, Sinéad Delany‐Moretlwe, Sybil Hosek et al.|PLoS Medicine|2021Cited by 181
Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–NaloxoneDavid S. Metzger, David Burns, Liu Wei et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2015Cited by 34
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trialSrilatha Edupuganti, Bethany Coomes, Christopher B. Hurt et al.|The Lancet HIV|2024Cited by 12